Chapter/Section Purchase

1 Study Coverage
1.1 Tumor Ablation Devices Product Introduction
1.2 Global Tumor Ablation Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Tumor Ablation Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Tumor Ablation Devices Sales in Volume for the Year 2017-2028
1.3 United States Tumor Ablation Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Tumor Ablation Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Tumor Ablation Devices Sales in Volume for the Year 2017-2028
1.4 Tumor Ablation Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Tumor Ablation Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Tumor Ablation Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Tumor Ablation Devices Market Dynamics
1.5.1 Tumor Ablation Devices Industry Trends
1.5.2 Tumor Ablation Devices Market Drivers
1.5.3 Tumor Ablation Devices Market Challenges
1.5.4 Tumor Ablation Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Tumor Ablation Devices Market Segment by Type
2.1.1 Microwave Ablation
2.1.2 Laser Ablation
2.1.3 Ultrasound Ablation
2.2 Global Tumor Ablation Devices Market Size by Type
2.2.1 Global Tumor Ablation Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Tumor Ablation Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Tumor Ablation Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Tumor Ablation Devices Market Size by Type
2.3.1 United States Tumor Ablation Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Tumor Ablation Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Tumor Ablation Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Tumor Ablation Devices Market Segment by Application
3.1.1 Urological Surgery
3.1.2 Gynecological Surgery
3.1.3 General Surgery
3.1.4 Gastrointestinal Surgery
3.1.5 Others
3.2 Global Tumor Ablation Devices Market Size by Application
3.2.1 Global Tumor Ablation Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Tumor Ablation Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Tumor Ablation Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Tumor Ablation Devices Market Size by Application
3.3.1 United States Tumor Ablation Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Tumor Ablation Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Tumor Ablation Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Tumor Ablation Devices Competitor Landscape by Company
4.1 Global Tumor Ablation Devices Market Size by Company
4.1.1 Top Global Tumor Ablation Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Tumor Ablation Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Tumor Ablation Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Tumor Ablation Devices Price by Manufacturer (2017-2022)
4.2 Global Tumor Ablation Devices Concentration Ratio (CR)
4.2.1 Tumor Ablation Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Tumor Ablation Devices in 2021
4.2.3 Global Tumor Ablation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Tumor Ablation Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Tumor Ablation Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Tumor Ablation Devices Product Type
4.3.3 Date of International Manufacturers Enter into Tumor Ablation Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Tumor Ablation Devices Market Size by Company
4.5.1 Top Tumor Ablation Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Tumor Ablation Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Tumor Ablation Devices Sales by Players (2020, 2021 & 2022)
5 Global Tumor Ablation Devices Market Size by Region
5.1 Global Tumor Ablation Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Tumor Ablation Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Tumor Ablation Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Tumor Ablation Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Tumor Ablation Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Tumor Ablation Devices Sales in Value by Region: 2017-2022
5.3.2 Global Tumor Ablation Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Tumor Ablation Devices Market Size YoY Growth 2017-2028
6.1.2 North America Tumor Ablation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Tumor Ablation Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Tumor Ablation Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Tumor Ablation Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Tumor Ablation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Tumor Ablation Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Tumor Ablation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Tumor Ablation Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Tumor Ablation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Ethicon
7.1.1 Ethicon Corporation Information
7.1.2 Ethicon Description and Business Overview
7.1.3 Ethicon Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ethicon Tumor Ablation Devices Products Offered
7.1.5 Ethicon Recent Development
7.2 Karl Storz
7.2.1 Karl Storz Corporation Information
7.2.2 Karl Storz Description and Business Overview
7.2.3 Karl Storz Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Karl Storz Tumor Ablation Devices Products Offered
7.2.5 Karl Storz Recent Development
7.3 Intuitive Surgical
7.3.1 Intuitive Surgical Corporation Information
7.3.2 Intuitive Surgical Description and Business Overview
7.3.3 Intuitive Surgical Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Intuitive Surgical Tumor Ablation Devices Products Offered
7.3.5 Intuitive Surgical Recent Development
7.4 Medtronic
7.4.1 Medtronic Corporation Information
7.4.2 Medtronic Description and Business Overview
7.4.3 Medtronic Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Medtronic Tumor Ablation Devices Products Offered
7.4.5 Medtronic Recent Development
7.5 Olympus
7.5.1 Olympus Corporation Information
7.5.2 Olympus Description and Business Overview
7.5.3 Olympus Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Olympus Tumor Ablation Devices Products Offered
7.5.5 Olympus Recent Development
7.6 Aesculap
7.6.1 Aesculap Corporation Information
7.6.2 Aesculap Description and Business Overview
7.6.3 Aesculap Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Aesculap Tumor Ablation Devices Products Offered
7.6.5 Aesculap Recent Development
7.7 Applied Medical
7.7.1 Applied Medical Corporation Information
7.7.2 Applied Medical Description and Business Overview
7.7.3 Applied Medical Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Applied Medical Tumor Ablation Devices Products Offered
7.7.5 Applied Medical Recent Development
7.8 B. Braun Melsungen
7.8.1 B. Braun Melsungen Corporation Information
7.8.2 B. Braun Melsungen Description and Business Overview
7.8.3 B. Braun Melsungen Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 B. Braun Melsungen Tumor Ablation Devices Products Offered
7.8.5 B. Braun Melsungen Recent Development
7.9 CareFusion
7.9.1 CareFusion Corporation Information
7.9.2 CareFusion Description and Business Overview
7.9.3 CareFusion Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 CareFusion Tumor Ablation Devices Products Offered
7.9.5 CareFusion Recent Development
7.10 Conmed
7.10.1 Conmed Corporation Information
7.10.2 Conmed Description and Business Overview
7.10.3 Conmed Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Conmed Tumor Ablation Devices Products Offered
7.10.5 Conmed Recent Development
7.11 Davol
7.11.1 Davol Corporation Information
7.11.2 Davol Description and Business Overview
7.11.3 Davol Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Davol Tumor Ablation Devices Products Offered
7.11.5 Davol Recent Development
7.12 Encision
7.12.1 Encision Corporation Information
7.12.2 Encision Description and Business Overview
7.12.3 Encision Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Encision Products Offered
7.12.5 Encision Recent Development
7.13 Eon Surgical
7.13.1 Eon Surgical Corporation Information
7.13.2 Eon Surgical Description and Business Overview
7.13.3 Eon Surgical Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Eon Surgical Products Offered
7.13.5 Eon Surgical Recent Development
7.14 Gyrus ACMI
7.14.1 Gyrus ACMI Corporation Information
7.14.2 Gyrus ACMI Description and Business Overview
7.14.3 Gyrus ACMI Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Gyrus ACMI Products Offered
7.14.5 Gyrus ACMI Recent Development
7.15 Integra LifeSciences
7.15.1 Integra LifeSciences Corporation Information
7.15.2 Integra LifeSciences Description and Business Overview
7.15.3 Integra LifeSciences Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Integra LifeSciences Products Offered
7.15.5 Integra LifeSciences Recent Development
7.16 IMRIS
7.16.1 IMRIS Corporation Information
7.16.2 IMRIS Description and Business Overview
7.16.3 IMRIS Tumor Ablation Devices Sales, Revenue and Gross Margin (2017-2022)
7.16.4 IMRIS Products Offered
7.16.5 IMRIS Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Tumor Ablation Devices Industry Chain Analysis
8.2 Tumor Ablation Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Tumor Ablation Devices Distributors
8.3 Tumor Ablation Devices Production Mode & Process
8.4 Tumor Ablation Devices Sales and Marketing
8.4.1 Tumor Ablation Devices Sales Channels
8.4.2 Tumor Ablation Devices Distributors
8.5 Tumor Ablation Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer